Structural transitions under high-pressure in a langasite-type multiferroic Ba3TaFe3Si2O14

The iron containing langasite family compound Ba₃Ta⁵⁷Fe₃Si₂O₁₄ was studied at high pressure up to 30 GPa at room temperature by means of in situ X-ray diffraction, Raman and Mössbauer spectroscopies in diamond anvil cell. Two structural transitions at pressures ∼5 and ∼20 GPa are observed. At ∼5 GPa, the low-pressure trigonal P321 phase undergoes phase transition to the most likely P3 structure as manifested by slight increase in the c/a ratio and by anomalies of the Mössbauer and Raman spectra parameters. At ∼20 GPa, the first order phase transition to monoclinic structure occurred with a drop of unit cell volume by 9%. The appearance of the ferroelectric state at such transitions is discussed in connection with the multiferroic properties.     

Target‐Based Whole‐Cell Screening by 1H NMR Spectroscopy

An NMR‐based approach marries the two traditional screening technologies (phenotypic and target‐based screening) to find compounds inhibiting a specific enzymatic reaction in bacterial cells. Building on a previous study in which it was demonstrated that hydrolytic decomposition of meropenem in living Escherichia coli cells carrying New Delhi metallo‐β‐lactamase subclass 1 (NDM‐1) can be monitored in real time by NMR spectroscopy, we designed a cell‐based NMR screening platform. A strong NDM‐1 inhibitor was identified with cellular IC₅₀ of 0.51 μM , which is over 300‐fold more potent than captopril, a known NDM‐1 inhibitor. This new screening approach has great potential to be applied to targets in other cell types, such as mammalian cells, and to targets that are only stable or functionally competent in the cellular environment.     

Covalent Attachment of Cyclic TAT Peptides to GFP Results in Protein Delivery into Live Cells with Immediate Bioavailability

The delivery of free molecules into the cytoplasm and nucleus by using arginine‐rich cell‐penetrating peptides (CPPs) has been limited to small cargoes, while large cargoes such as proteins are taken up and trapped in endocytic vesicles. Based on recent work, in which we showed that the transduction efficiency of arginine‐rich CPPs can be greatly enhanced by cyclization, the aim was to use cyclic CPPs to transport full‐length proteins, in this study green fluorescent protein (GFP), into the cytosol of living cells. Cyclic and linear CPP–GFP conjugates were obtained by using azido‐functionalized CPPs and an alkyne‐functionalized GFP. Our findings reveal that the cyclic‐CPP–GFP conjugates are internalized into live cells with immediate bioavailability in the cytosol and the nucleus, whereas linear CPP analogues do not confer GFP transduction. This technology expands the application of cyclic CPPs to the efficient transport of functional full‐length proteins into live cells.     

In vitro evaluation of antiproliferative effect of ethyl gallate against human oral squamous carcinoma cell line KB

Although some polyphenols are known to possess anticancer activity against different cancer cell lines through induction of apoptosis, the mode of antiproliferative effect of ethyl gallate against human oral squamous carcinoma cell line KB was not studied until now. Therefore, the antiproliferative effect of ethyl gallate was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay in comparison with the reference drug paclitaxel. Generation of reactive oxygen species, mitochondrial membrane potential loss, DNA damage and apoptosis were determined using 2,7-diacetyldichlorofluorescein fluorescence, uptake of rhodamine-123 by mitochondria, comet assay and acridine orange/ethidium bromide dual-dye staining method. Both ethyl gallate and paclitaxel exhibited cytotoxicity in a dose-dependent manner. The 50% inhibitory concentration for ethyl gallate was 30 and 20 μg/mL for paclitaxel. A volume of 50 μg/mL of ethyl gallate was found to be significantly effective (P < 0.05) in controlling the cancer cell proliferation leading to acute apoptosis.     

A novel quantitative model of cell cycle progression based on cyclin-dependent kinases activity and population balances

Cell cycle regulates proliferative cell capacity under normal or pathologic conditions, and in general it governs all in vivo/in vitro cell growth and proliferation processes. Mathematical simulation by means of reliable and predictive models represents an important tool to interpret experiment results, to facilitate the definition of the optimal operating conditions for in vitro cultivation, or to predict the effect of a specific drug in normal/pathologic mammalian cells. Along these lines, a novel model of cell cycle progression is proposed in this work. Specifically, it is based on a population balance (PB) approach that allows one to quantitatively describe cell cycle progression through the different phases experienced by each cell of the entire population during its own life. The transition between two consecutive cell cycle phases is simulated by taking advantage of the biochemical kinetic model developed by Gérard and Goldbeter (2009) which involves cyclin-dependent kinases (CDKs) whose regulation is achieved through a variety of mechanisms that include association with cyclins and protein inhibitors, phosphorylation–dephosphorylation, and cyclin synthesis or degradation. This biochemical model properly describes the entire cell cycle of mammalian cells by maintaining a sufficient level of detail useful to identify check point for transition and to estimate phase duration required by PB. Specific examples are discussed to illustrate the ability of the proposed model to simulate the effect of drugs for in vitro trials of interest in oncology, regenerative medicine and tissue engineering.     

Study of the Function of G‐Rich Aptamers Selected for Lung Adenocarcinoma

Guanine (G)‐rich oligonucleotides have attracted considerable interest as therapeutic agents. Two G‐rich aptamers were selected against epidermal growth factor receptor (EGFR)‐transfected A549 cells, and their G‐rich domains (S13 and S50) were identified to account for the binding of parental aptamers. Circular dichroism (CD) spectra showed that S13 and S50 bound to their targets by forming parallel quadruplexes. Their binding, internalization, and antiproliferation activity in cancer and noncancer cells were investigated by flow cytometry and 3‐(4,5‐dimethylthiazol‐2‐yl)‐5‐(3‐carboxymethoxyphenyl)‐2‐(4‐sulfophenyl)‐2H‐tetrazolium (MTS) assay, and compared with those of nucleolin‐binding AS1411 and thrombin‐binding aptamer. The two truncated aptamers (S13 and S50) have good binding and internalization in cancer cells and noncancer cells; however, only S50, similar to AS1411, shows potent antiproliferation against cancer cells. Our data suggest that tumor‐selective antiproliferation of G‐rich oligonucleotides does not directly depend on the binding of the G‐rich aptamer to cells.     

Electrochemical characterization of MnO2 as electrocatalytic energy material for fuel cell electrode

 Development of inexpensive non Pt based high electrocatalytic energy materials is the need of the hour for fuel cell electrode to produce clean alternative green energy from synthesized bio alcohol using biomass. MnO₂, electro synthesized at different current density is found to be well performed electrocatalytic material, comparable to Pt, with higher current density, very low overvoltage for the electrochemical oxidation of methanol. From EIS study, the polarization resistance of the coated MnO₂ is found to be much low and electrical double layer capacitance is high, the effect increases with increase in current density of electro deposition. XRD, EDX and AAS analysis confirm the MnO₂ deposition. The morphology of SEM images exhibits an enhanced 3D effective substrate area, for electro oxidation of the fuel. A few nano structured grains of the deposited MnO₂ is also observed at higher current density. The fact supports that a high energetic inexpensive electro catalytic material has been found for fuel cell electrode to synthesis renewable energy from methanol fuel.     

IL-24重组载体的构建及其联合化疗药物对SKOV3细胞中TUBB3与ERCC-1基因表达的影响

通过基因重组技术将白介素24(IL-24)基因片段分别克隆成pc DNA3.0-OSP-1-IL-24和pc DNA3.0-IL-24载体,利用逆转录PCR(RT-PCR)测定2种载体的表达.将2种化疗药物紫杉醇(PTX)与顺铂(DDP)分别作用于正常SKOV3细胞及pc DNA3.0,pc DNA3.0-IL-24,pc DNA3.0-OSP-1和pc DNA3.0-OSP-1-IL-24稳定转染SKOV3细胞(卵巢癌细胞株),通过噻唑蓝(MTT)法检测化疗药物联合IL-24基因对细胞的杀伤效果及细胞的增殖能力,应用实时荧光定量PCR技术检测人β-微管蛋白3(TUBB3)与核苷酸切除修复交叉互补基因位1(ERCC1)基因在各组细胞中的表达.RT-PCR检测结果显示,通过基因重组技术克隆了pc DNA3.0-IL-24与pc DNA3.0-OSP-1-IL-24载体,IL-24基因能提高SKOV3细胞对化疗药物顺铂和紫杉醇的敏感性.其联合化疗药物对肿瘤药物的IC50值分别下降了10倍和6倍,TUBB3和ERCC1基因在IL-24基因转染的SKOV3细胞内的表达水平与在正常SKOV3细胞内相比,分别下降4倍和10倍多.上述结果表明,IL-24联合化疗药物可明显下调TUBB3与ERCC1基因的表达,该实验为临床治疗卵巢癌提供了重要的理论依据.